Caiazza F, McGowan PM, Mullooly M, Murray A, et al. Correction: Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells. Br J Cancer 2025 Mar 14. doi: 10.1038/s41416-025-02973.
PMID: 40087384